Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,471,923
-$6,166,799 QoQ
Shares Held
511,329
-38.3% QoQ
Ownership
0.652%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. CRMD ranks #195 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in CRMD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,471,923 | 511,329 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,638,722 | 828,781 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,684,319 | 230,810 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,422,124 | 196,601 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,107,554 | 179,798 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,611,251 | 198,920 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,093,934 | 135,388 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $306,519 | 70,790 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $176,862 | 41,713 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $139,308 | 37,050 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $158,814 | 42,923 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $43,594 | 10,981 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $105,295 | 26,193 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $250,118 | 45,642 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $306,483 | 67,359 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $146,977 | 31,608 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $182,537 | 26,609 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $614,194 | 61,481 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $144,580 | 19,459 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $61,885 | 10,263 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||